Archive for the ‘research’ Category

First Cancer Protocol using Ivermectin, Mebendazole, and Fenbendazole Published

**UPDATE**

Recently, a previously declassified CIA document  has gone viral.  The doc summarizes a Soviet scientific paper that showed researchers believed parasites and cancer thrived under nearly identical metabolic conditions and accumulated large reserves of glycogen, a form of stored energy.

  • Myracyl D, Miracel D, Lucanthone, was reportedly effective against bilharzia parasites as well as cancerous growths. It has never been approved for medicinal use as chemo and has been tested in human clinical trials and is used in research. It is no longer commonly used in humans due to hepatotoxicity.[4]
  • Other compounds were found to interfere with nucleic acid production, a process essential for the uncontrolled growth of cancer cells.

It’s important to note that the document did not directly state that cancer was caused by parasites, only that there are biochemical similarities; however, this further proves why drugs like ivermectin, Mebendazole and Fenbendazole are helping cancer patients.

Go here to listen to an interview with Dr. Lee Merritt on how historical experiments showed parasites could induce stomach cancer in animals eating a high sugar diet or were vaccinated. She also questions how diet, vaccination and parasite susceptibility might intersect.

Since the paper below was published, there’s only been more success using repurposed drugs.  Also, a 2021 patent by Johns Hopkins University was unearthed for glioblastoma therapy using Mebendazole.

If you like getting information via video, go here for a 6 minute summary of the following paper.

https://isom.ca/article/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment-a-hybrid-orthomolecular-protocol/

Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolectular Protocol

Ilyes Baghli1, William Makis2, Paul E. Marik3, Michael J. Gonzalez4,5,6, William B. Grant7, Ron Hunninghake8, Thomas E. Levy8, Homer Lim9, Richard Z. Cheng10, Igor Bondarenko11, Paul Bousquet12, Roberto Ortiz13, Mignonne Mary14, Dominic P. D’Agostino15, Pierrick Martinez16

Date of Publication: 19 September 2024

Abstract

The mitochondrial-stem cell connection (MSCC) theory suggests that cancer originates from chronic oxidative phosphorylation (OxPhos) insufficiency in stem cells. This OxPhos insufficiency leads to the formation of cancer stem cells (CSCs) and abnormal energy metabolism, ultimately resulting in malignancy. This concept integrates two well-established theories: the cancer stem cell theory and the metabolic theory. Drawing on insights from molecular biology, pharmacology, and clinical studies, this manuscript introduces a hybrid orthomolecular protocol targeting the MSCC. The protocol includes 7 therapeutic recommendations, consisting of orthomolecules, drugs, and additional therapies. The aim of this hybrid orthomolecular protocol is to achieve additive and synergistic effects to enhance OxPhos, inhibit the primary fuels of cancer cells (glucose and glutamine), target CSCs and metastasis. Thus, numerous experiments suggest that targeting MSCC could be a potential therapeutic approach for cancer treatment.  (See link for study)

_________________

http://

Fenben For Cancer Case Presentations

Three patients with various genitourinary malignancies, who demonstrated complete response after receiving FBZ therapy, as a single or supplementary chemotherapeutic agent. In two patient scenarios, they had experienced progression of metastatic disease despite multiple lines of therapy prior to initiation of FBZ. No side effects from FBZ were reported.

As to cancer…every cancer registry in the world is up with new cases and documented rapid progression of disease aptly termed “turbo cancer.” Cases are up by 2.5X in New York state Medicaid vs. a 2017-2019 baseline, and The American Cancer Society states that this year the number of newly diagnosed cases of cancer will surpass  the 2 million mark for the first time ever.

The trendline went up with the rollout of genetic COVID-19 injections.

And it’s not like the FDA didn’t know.  The Moderna patent explains that when a foreign DNA sequence integrates with a host organism’s genome, it could lead to the activation of oncogenes, mutated genes that have the potential to cause cancer, or the inhibition of tumor suppression genes.  Researchers in the U.S. and Canada recently found DNA fragments in COVID-19 mRNA shots.

Go here for a review of a study that shows repeated injections of mRNA COVID-19 injections are taking down immune surveillance for nascent malignant cells while at the same time inducing autoimmunity.  

How was this allowed to happen?

Manufacturers skipped preclinical oncogenicity studies.

The COVID shots are highly contaminated with plasmids, SV40 sequences that have been linked to cancer, metals, PEG, nanotechnology, lipid nanoparticles, black particles, white floating matter, impurities from human fetal cell lines, hexagonal crystalline structures, parasites and eggs, and a hydra-like moving, self aware organisms.

But, according to the CDC, more than 240 billion dollars will be spent on cancer care in the United States on a yearly basis by 2030.  Just think about that.  That is close to a quarter of a trillion dollars going into the pockets of certain people and organizations.

Go here to download for FREE Dr. Marik’s entire book: Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer, as well as webinar slides, cancer care summary, FLCCC cancer study, and also watch numerous videos.  You know an expert is serious when they make their hard work available for all at no cost.

For more:

http://  Scroll to 7:30

Ivermectin for Cancer

Oct. 12, 2024

Listen to Dr. Kathleen Ruddy, surgeon, researcher, and author on how ivermectin not only works for COVID but has 20 years of research showing its potential for cancer.  She met a previously healthy patient who ran marathons with no family history of cancer, but who developed stage 4 prostate cancer after being forced to get two Pfizer shots to keep his government job.  Under another doctor he did 9 months of radiation and chemotherapy only to be told, there’s nothing more to be done, go home and prepare to die.  At this point Ruddy met him and suggested he try ivermectin as she knew it wouldn’t hurt him and might help.  He drove to Tennessee where he paid cash for it as it was an over-the-counter drug there.  A few months after taking it he had his PSA checked which went from in the hundreds to 1.3 which is considered normal.  Nine months later he’s out dancing 3 nights a week for four hours.  A scan showed 3 of the four bone masses are gone.  

Category:

Cancer, research, Treatment

Borrelia burgdorferi: Methods and Protocols

https://link.springer.com/book/10.1007/978-1-0716-3561-2#about-this-book

Borrelia burgdorferi: Methods and Protocols

2024

Editors:
Leona Gilbert
  • Includes cutting-edge methods and protocols
  • Provides step-by-step detail essential for reproducible results
  • Contains key notes and implementation advice from the experts

About this book

This volume covers the latest advancements and techniques used to understand the fastidious bacterium, Borrelia burgdorferi, and its significance in infectious disorders by combining both conventional and cutting-edge approaches. This book covers diverse topics, including direct detection, diagnostic methods, immune response analysis, alternative model systems, advanced proteomics, social media analysis, and clinical research. It also discusses unconventional wet lab research such as content analysis, the use of ChatGPT, clinical algorithms for chronic Lyme, establishment of a pregnancy Lyme disease biobank, and investigates Lyme in pregnant women. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Cutting-edge and comprehensive, Borrelia burgdorferi: Methods and Protocols encompasses a wide range of techniques and caters to scientists from various disciplines and career stages, such as cell and molecular biologists, statisticians, and clinical researchers.

Category:

Activism, Lyme, Pregnancy, research

AMA Lyme Disease: A Clinician Toolkit (Part 2)

I must have missed Part 1.  Here it is:  https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

In short, the CDC gave the AMA 5M in taxpayer dollars to come up with an IDSA Toolkit to improve care for patients with prolonged symptoms and concerns about Lyme disease.

Hopefully you can see the inherent problems with this.  Once again, the wolf is being asked how to take care of the chickens.  Dr. Paul Auwaerter particularly appears to speak out of both sides of his mouth.

Further, the American Medical Association (AMA) is a completely corrupt, tyrannical institution.  It opposes free speech, instructs doctors to deceive, is behind persecuting doctors who think for themselves, was found GUILTY in a court of law of conspiring against chiropractic, and has completely monopolized medicine with the help of the Rockefellers.

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32919062?

American Medical Association Lyme Disease: A Clinician Toolkit (Part 2)

Carl Tuttle
Hudson, NH, United States
Sep 25, 2024

The letter below is a follow-up to the previous petition update: https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>, “pgauwaerter@gmail.com” <pgauwaerter@gmail.com>
Cc: “cbb0@cdc.gov” <cbb0@cdc.gov>, “jjohnson@genevausa.org” <jjohnson@genevausa.org>, “theerhisamariee@gmail.com” <theerhisamariee@gmail.com>, “jaucott@jhmi.edu” <jaucott@jhmi.edu>, “jraitt1@stanford.edu” <jraitt1@stanford.edu>, “dclauw@med.umich.edu” <dclauw@med.umich.edu>, “john.leong@tufts.edu” <john.leong@tufts.edu>, “avindra.nath@nih.gov” <avindra.nath@nih.gov>, “charles.chiu@ucsf.edu” <charles.chiu@ucsf.edu>, “elliot.cowan@partnersindiagnostics.com” <elliot.cowan@partnersindiagnostics.com>, “beth.jaworski@nih.hhs.gov” <beth.jaworski@nih.hhs.gov>, “roger@lundquist.org” <roger@lundquist.org>, “rachele.hendricks.sturrup@duke.edu” <rachele.hendricks.sturrup@duke.edu>, “info@lymebiobank.org” <info@lymebiobank.org>, “lorrainejohnson@outlook.com” <lorrainejohnson@outlook.com>, “wendyadams1@gmail.com” <wendyadams1@gmail.com>, “Leith.States@hhs.gov” <Leith.States@hhs.gov>, “tindall.matt@gmail.com” <tindall.matt@gmail.com>, “stacie.hudgens@clinoutsolutions.com” <stacie.hudgens@clinoutsolutions.com>, “raymond_dattwyler@nymc.edu” <raymond_dattwyler@nymc.edu>, “timothy.sellati@globallymealliance.org” <timothy.sellati@globallymealliance.org>, “nklimas@nova.edu” <nklimas@nova.edu>, “kester@genevausa.org” <kester@genevausa.org>, “nicole@nicolemalachowski.com” <nicole@nicolemalachowski.com>, “marcom@genevausa.org” <marcom@genevausa.org>, “stephen.gluckman@pennmedicine.upenn.edu” <stephen.gluckman@pennmedicine.upenn.edu>, “epocratesMedia@athenahealth.com” <epocratesMedia@athenahealth.com>, “epocrates@athenahealth.com” <epocrates@athenahealth.com>, “achen@mathematica-mpr.com” <achen@mathematica-mpr.com>, “info@mathematica-mpr.com” <info@mathematica-mpr.com>, “pdecker@mathematica-mpr.com” <pdecker@mathematica-mpr.com>, “lwx1@cdc.gov” <lwx1@cdc.gov>, “frederick.chen@ama-assn.org” <frederick.chen@ama-assn.org>, “gmarx@cdc.gov” <gmarx@cdc.gov>, “acoyne@mathematica-mpr.com” <acoyne@mathematica-mpr.com>, “jconstantine@mathematica-mpr.com” <jconstantine@mathematica-mpr.com>, “ctrenholm@mathematica-mpr.com” <ctrenholm@mathematica-mpr.com>, “tbarnes@mathematica-mpr.com” <tbarnes@mathematica-mpr.com>, “sboudreau@mathematica-mpr.com” <sboudreau@mathematica-mpr.com>, “jdevallance@mathematica-mpr.com” <jdevallance@mathematica-mpr.com>, “sara.berg@ama-assn.org” <sara.berg@ama-assn.org>, “jack.resneck@ucsf.edu” <jack.resneck@ucsf.edu>, “jack.resneck@ama-assn.org” <jack.resneck@ama-assn.org>, “todd.unger@ama-assn.org” <todd.unger@ama-assn.org>, “jon.burkhart@ama-assn.org” <jon.burkhart@ama-assn.org>, “karen.kmetik@ama-assn.org” <karen.kmetik@ama-assn.org>, “sanjay.desai@ama-assn.org” <sanjay.desai@ama-assn.org>, “aaguilar@webmd.net” <aaguilar@webmd.net>, “DFlapan@Medscape.net” <DFlapan@Medscape.net>, “lkane@medscape.net” <lkane@medscape.net>, “gamiller@medscape.net” <gamiller@medscape.net>, “dolmos@webmd.net” <dolmos@webmd.net>, “sarah.wright@webmd.net” <sarah.wright@webmd.net>, “editor2@webmd.net” <editor2@webmd.net>, “kg@kirstengillibrand.com” <kg@kirstengillibrand.com>, “yzhang207@zju.edu.cn” <yzhang207@zju.edu.cn>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>, “Antitrust.ATR@usdoj.gov” <Antitrust.ATR@usdoj.gov>, “gheltzer@mwe.com” <gheltzer@mwe.com>, “albert.sambat@usdoj.gov” <albert.sambat@usdoj.gov>, “ddutko@rustyhardin.com” <ddutko@rustyhardin.com>, “kspeer@rustyhardin.com” <kspeer@rustyhardin.com>, “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “loppenheimer@oppenheimer-law.com” <loppenheimer@oppenheimer-law.com>

Date: 09/25/2024 9:20 AM EDT
Subject: Re: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease: A Clinician Toolkit

Dr Auwaerter,

While we wait for your reply to my previous inquiry dated Sept 2nd, I would like to call attention to the following publication you coauthored with Johns Hopkins colleague Dr. Ying Zhang in 2014:

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library – PubMed
Jie Feng, Ting Wang, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G Auwaerter & Ying Zhang

https://pubmed.ncbi.nlm.nih.gov/26038747/

Excerpt:

Findings that suggest the continued presence of B. burgdorferi in some form indicate that current Lyme disease treatment may not sufficiently eliminate B. burgdorferi persisters or that the immune system fails to clear persisting organisms or bacterial debris, which may be the underlying cause for those who suffer from unresolved Lyme disease symptoms.
Recent quote from Dr. Ying Zhang: (Now with Zhejiang University School of Medicine, Hangzhou, Zhejiang, China)

“We’re dealing with a very unique situation here. The current Lyme antibiotic does not completely eradicate Borrelia bacteria. We found this dandelion phenomenon. The mower is equivalent to the antibiotics, that chopped off the top part. But because the root, the possessor, is still there, they can grow back. You need drugs targeting both parts in order to more effectively cure this persistent form of the disease.”

Dr Auwaerter,

These findings appear to be missing from your recorded interview on the AMA website: “Toolkit to Improve Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease”

For the record there are seven published studies finding Dapsone effective in treating chronic Lyme disease as reported by Dr. Richard Horowitz and colleagues: 1, 2, 3, 4, 5, 6, 7

In contrast Dr. Auwaerter, you were the lead author who published the hit piece in the Lancet Infectious Diseases condemning these physicians:

Antiscience and ethical concerns associated with advocacy of Lyme disease (2011)
https://pubmed.ncbi.nlm.nih.gov/21867956/

The 5-million-dollar grant given to the AMA by the CDC for this so-called “Clinician Toolkit” would have been better spent on validating antimicrobials that cure chronic Lyme. But then again if we had the correct treatment who would opt for Pfizer’s Lyme vaccine currently in phase III clinical trials ready to roll out in 2026?

Questions:

Which CDC employee/academic stands to benefit financially (patent royalties etc.) from the soon to be released OspA Pfizer Lyme vaccine and what role have these individuals played (if any) in the ongoing collusion to deny chronic Lyme disease? 

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse
Attorneys for the United States Antitrust Division

Assistant Attorney General Jonathan Kanter Announces Task Force on Health Care Monopolies and Collusion
https://www.justice.gov/opa/pr/assistant-attorney-general-jonathan-kanter-announces-task-force-health-care-monopolies-and

References:

1. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections.
https://pubmed.ncbi.nlm.nih.gov/37764145/

2. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.
https://pubmed.ncbi.nlm.nih.gov/32993780/

3. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
https://pubmed.ncbi.nlm.nih.gov/35884166/

4. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review.
https://pubmed.ncbi.nlm.nih.gov/38792737/

5. Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review.
https://pubmed.ncbi.nlm.nih.gov/33105645/

6. Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1.
https://pubmed.ncbi.nlm.nih.gov/30863136/

7. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2.
https://pubmed.ncbi.nlm.nih.gov/30400667/
Previous inquiry to Auwaerter dated Sept 2nd:
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

Category:

Activism, Lyme, research, Treatment

Researchers Say New Lyme Test Can Detect Lyme Within 14 Days of Infection

https://www.lymedisease.org/detecting-lyme-within-14-days/

Researchers say this test can detect Lyme within 14 days of infection

Focus on Lyme and Aces Diagnostics Inc. has announced a breakthrough in Lyme disease diagnosis with a new test that detects the disease at all stages, including the crucial first 14 days post-infection, with over 90% accuracy.

Aces Diagnostics is developing and manufacturing this test, aiming for FDA clearance to make it accessible to all patients.

LymeSeek™, developed through a collaboration between Tulane University and Focus on Lyme, combines advanced biomarker research from Tulane’s Monica Embers and nine years of intensive work funded by Focus on Lyme. Enhanced by machine learning, this innovative diagnostic promises to reshape Lyme disease detection.

“Previous tests have been less than 50% accurate, especially in the early stages,” said Tammy Crawford, CEO of Aces Diagnostics. “This has led to countless patients being misdiagnosed or undiagnosed, resulting in prolonged suffering. LymeSeek will change that, providing a reliable diagnostic tool that can save lives.”

Aces Diagnostics Team

The CDC reports that nearly 500,000 people in the U.S. are diagnosed with Lyme disease each year. Globally, 14.5% of the population is affected, with many suffering from chronic symptoms due to delayed diagnosis. A Johns Hopkins study revealed that 38% of Lyme patients continue to experience symptoms six months post-diagnosis, underscoring the need for improved testing.

Simplifying diagnosis

“Current Lyme testing involves multiple steps, with results taking over a week and requiring subjective interpretation,” said Aces Diagnostics Co-Founder Holly Ahern.

“LymeSeek™ will replace this cumbersome process, enabling earlier diagnosis and reducing chronic illness caused by delayed or missed diagnoses.”

Crawford and Ahern are personally invested in this mission, both having daughters who battled Lyme disease. “An early diagnosis could have spared them years of suffering,” said Crawford.

Aces Diagnostics Inc. brings together a team with over 50 years of combined experience in Lyme disease research, backed by a distinguished advisory board that includes experts from Johns Hopkins University, Columbia University, and Tulane University. The company is already advancing development and manufacturing efforts and pursuing early FDA clearance to make LymeSeek™ available to the public by the third quarter of 2026.

SOURCE: Focus on Lyme

______________

**Comment**

Testing has been and continues to be a major problem with Lyme/MSIDS for numerous reasons, one of the biggest being the fact many are coinfected with numerous pathogens that mainstream medicine and research never discuss.  These coinfected patients are some of the sickest but are kicked to the curb because testing doesn’t reveal what’s inside them.

While this new test is a step in the right direction, it still doesn’t address those who have been infected for decades or those who are coinfected.  It’s like comparing apples to oranges and until these issues are addressed, it remains a foreign language to mainstream medicine.

The Johns Hopkins study showing nearly 40% go on to suffer symptoms 6 months post-diagnosis is still low in my opinion due to the fact so many are never diagnosed in the first place and so many are infected with multiple things that are never picked up on testing.

But, one must remain hopeful……

For more:

Category:

Lyme, research, Testing

A US Federal Agency’s Definitive Report on How Fluoride Harms Children’s Brains. What Now?

By Leo Cashman

9/19/24

Those who followed the multi-year fluoride trial saga know that the government’s much touted report on whether fluoride harms children’s brain has finally been released and seen the light of day. Getting it released at this late date wasn’t easy, as there seemed to be efforts to delay it and suppress it. It had been peer reviewed again, and reviewed again, to a farcical degree. 

Release of report halted 

Then, the report was finally completed and slated to be released in May of 2022. Its release was mysteriously halted, despite the fact that the judge in the fluoride trial was waiting for its release for more than a year, and it was supposedly needed in order to provide pivotal evidence in the trial after years of delay and waiting. Thanks to FOIA requests brought by the plaintiff’s attorneys, it was revealed that the release of the report had been secretly blocked by an order from someone high in the public health hierarchy: Admiral Levine, assistant Secretary of Health. The judge, exasperated, ordered that the preliminary version of the report be released to the court, so that its conclusions could be brought into evidence and the trial could be completed. This, on his part, allowed the final leg of the trial to be completed this past February; however, it is September, and we all are still awaiting a verdict. 

18 of 19 studies show impact on intelligence 

Now that we have the official National Toxicology Program (NTP) report, it is time to ask: what does it say? Are there any surprises to be found in it? In its description of the scientific details, the report did find confirmation, as expected, of fluoride as being toxic to children’s brains. Of the 19 highest quality studies, 18 of them found that higher levels of fluoride exposure were significantly associated with lower intelligence in children. But there were some statements in the report that will give the dental establishment something to cling to: the clearest evidence that fluoride is a brain neurotoxin was found at levels of 1.5 parts per million, which is higher than the 0.7 parts per million that the CDC now recommends for water fluoridation.

Multiplicity of factors add to fluoride exposure 

But a counter to that argument is that total fluoride intake – with some coming from food, toothpastes, drugs, and pollution – varies greatly, and susceptibility varies greatly too, with some people being harmed more easily than others. So, each side of the fluoride debate will still have talking points in the ongoing argument over fluoridation, and the big media will obviously favor the vested interests that make up the fluoride promoters. 

Fluoride in the food supply and pharmaceutical increase exposure 

Those who have followed the fluoride issue know how broad and powerful those players on the fluoride team are. Fluoride is found at much higher levels in many beverages and foods than it is in fluoridated water. So Big Ag and Big Food want the fluoride cover-up. Big Pharma knows that about ten per-cent of its drugs use fluorine as an ingredient, including Prozac and the notorious antibiotic, Cipro (They both carry FDA black box warnings). Heavy industry, from steel to coal, aluminum factories and phosphate fertilizer plants pose a hazard to workers and nearby communities alike.

ADA and media can’t admit they were wrong 

In particular, the phosphate fertilizer plants are capturing their hazardous fluoride fumes to keep them out of the environment and then have the gall to sell them to chemical companies who peddle them to city water works, which put the toxic waste into the water people drink – that’s what is called water fluoridation. So heavy industry does want to let go of the myths about fluoride being “safe and effective.” Big dentistry, as with the American Dental Association doesn’t want to admit that it was profoundly wrong over the last 80 years in insisting that every dental student in every dental school be taught that fluoride use and water fluoridation are fundamentally needed to assure children’s dental health. Big media itself has a stake in the debate, because it doesn’t want to admit that it was profoundly negligent in its coverage of the fluoride issue over the last 80 years.

Team Fluoride 

Instead of telling the public about what honest scientists had actually found, it has steadfastly held to the lies and the cover-up of the dental-industrial-governmental establishment when telling us what to believe. So, we shouldn’t expect the big players of Team Fluoride to admit that they have been in the wrong, and this will even be true regardless of what the verdict the trial judge in the fluoride lawsuit comes up with. If the defendant, the Environmental Protection Agency loses, it likely may very well appeal the verdict, thus allowing the harm to America’s children to continue on for months and maybe years. 
Expert fired; computers destroyed by “accident”? It has never been easy for the scientific truth about fluoride to see the light of day. The great toxicologist Phyllis Mullenix, PhD, seemed destined to turn the tide against the fluoride myths when she found powerful evidence in 1989-1990 that fluoride was toxic to her test animals. 
She had the integrity to publish anyway, despite warnings that she would lose her prestigious job at the Forsyth Dental Institute, if she did so. By 1994, she had been given a termination notice from Forsyth and in the final months of being there before she left, her multi-million high tech computer equipment had been destroyed, harmed by an inexplicable “rain” that had fallen from the ceiling. And the well cared for test animals had mysteriously taken ill and died. She never got another NIH grant or a job anywhere, in any university or research facility. In recalling her treatment by Forsyth and by the NIH research establishment, she described her experience as “Mister Toad’s Wild Ride.”  
Crops and farm animals severely harmed She had come to know first-hand how government and industry bias could trump science of the highest quality. But to her astonishment, it would rise to new heights in 1997, after several reporters contacted her and told her about of the real origins of water fluoridation, going back to the 1940s and the atomic bomb project (“The Manhattan Project”). DuPont’s chemical facility in Deepwater, Delaware, was facing a flurry of lawsuits from farmers who, being near the plant, had crops and farm animals that were severely harmed by toxic fluoride from the chemical plant. The plant was being used to make uranium hexafluoride, needed for Uranium isotope separation for the bomb project. It was Harold Hodge, PhD, the bomb project’s chief fluoride expert, who boldly proposed that the dental establishment should send around a memo to the communities in New Jersey claiming, falsely of course, that a little bit of fluoride in their drinking water would protect children’s teeth from decay. 

Harold Hodge, PhD

America’s biggest scientific fraudster? 

Hodge also brazenly green-washed the image of fluoride for industrial plants that were exposing their workers to unsafe amounts of fluoride. Hodge’s own research found that fluoride was harmful to the dentician of workers – most of them lost all of their teeth! – but Hodge falsified the evidence in a published scientific article that provided for the fluoride cover-up needs of American industry, including the bomb project which employed tens of thousands of workers, many of whom were disabled and many who died. In short, Harold Hodge, who died in 1990, known as America’s leading fluoride expert, was actually America’s biggest scientific fraudster and one who did incalculable harm to America in the sweep of time since then. Most people never learn that there is such a thing as a criminal-scientist. 
CIA and Department of Defense role? 

The revelations about the origins of fluoridation, Harold Hodge, and the bomb project particularly touched Phyllis Mullenix personally when she learned about them in 1997. For, the bizarre twist is that in the final years of Hodge’s life, he worked at Forsyth Dental Institute alongside Phyllis Mullenix as a sort of a fluoride research team helper. In a kindly way, he was always curious about her progress and what she was finding out. What she was finding out in 1989-1990, Harold Hodge had already secretly discovered half a century earlier in the 1940s, reported to all the players in government and the defense department but then lied about in his statements to the media and the public and in his published scientific papers. His role at Forsyth was, in all probability, to be a mole, to report the research findings to the CIA (which he had deep connections with) as well as the DOD and other government contacts. He was likely a spy for those who wanted to know the scientific truth but also to keep a lid on what the public would be allowed to know.

Expert asked not to publish findings 

So, with that, Phyllis more fully understood the depth of the fluoride cover-up. The powers that be wanted to know the truth about fluoride, including its harmful effects on the brain and behavior. But that was to better manage the use of fluoride and its impacts on brains and behavior, not to reverse course on a program that was harming American’s health. When they brazenly asked her not to publish her important results, they expected her to fall in line and keep quiet to protect her career as a scientist. 

Christopher Bryson

The Fluoride Deception 

This story and much more is covered in Christopher Bryson’s book The Fluoride Deception (2004). At 374 pages, and with thousands of scientific references and citations, this is the work of a brave world-class investigative journalist who covered the scientific excellence and bravery of the top scientific researchers of the last century. The book has chapters on Europe’s top fluoride researcher, Kaj Roholm. Back in the 1940s, Roholm was a brilliant and honest Danish researcher who, unlike Harold Hodge, told the truth on his continent publishing a 354-page book on it. But because of Roholm’s integrity, most of mainland Europe learned of the harmful effects of fluoride and never fluoridated its water. 

EPA “experts” ignorant of key research

In the closing hours of the epochal fluoride trial, EPA’s science expert, David Savitz was asked to comment on the work of Phyllis Mullenix and Kaj Roholm. But he claimed he knew nothing of them and had never heard of them. So, the works of Mullenix and Roholm never became part of the record in the fluoride trial because EPA ‘experts’ knew nothing about them.

Conclusion? What most people believe about fluoride is based on questionable science. That is the intended result of decades of media-government and ADA misinformation. That misinformation persists regardless of what Phyllis Mullenix or any other scientist has published. Old cover-ups die hard. There are powerful interests that want to keep them in place. Do not expect to be handed the truth on a silver platter by a governmental agency. If a governmental body imposes a heavy-handed health measure on you, it is good to be skeptical and to push back. 

For more:

Category:

Activism, Dentistry, research